The product is currently used in the treatment of cryopyrin-associated periodic syndrome. In May 2012, an advisory panel voted 11-0 against the use of the product for the treatment of gout.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
